ID   SCAP_HUMAN              Reviewed;        1279 AA.
AC   Q12770; Q8N2E0; Q8WUA1;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 4.
DT   28-JAN-2026, entry version 218.
DE   RecName: Full=Sterol regulatory element-binding protein cleavage-activating protein {ECO:0000303|PubMed:10570913};
DE            Short=SCAP {ECO:0000303|PubMed:10570913};
DE            Short=SREBP cleavage-activating protein {ECO:0000303|PubMed:10570913};
GN   Name=SCAP {ECO:0000303|PubMed:10570913, ECO:0000312|HGNC:HGNC:30634};
GN   Synonyms=KIAA0199 {ECO:0000303|PubMed:8724849};
GN   ORFNames=PSEC0227 {ECO:0000303|PubMed:16303743};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hepatoma;
RX   PubMed=10570913; DOI=10.1007/s100380050187;
RA   Nakajima T., Hamakubo T., Kodama T., Inazawa J., Emi M.;
RT   "Genomic structure and chromosomal mapping of the human sterol regulatory
RT   element binding protein (SREBP) cleavage-activating protein (SCAP) gene.";
RL   J. Hum. Genet. 44:402-407(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V. The
RT   coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 350-1278 (ISOFORM 3).
RC   TISSUE=Embryo;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [7]
RP   INDUCTION.
RX   PubMed=15133039; DOI=10.1074/jbc.m401615200;
RA   Heemers H., Verrijdt G., Organe S., Claessens F., Heyns W., Verhoeven G.,
RA   Swinnen J.V.;
RT   "Identification of an androgen response element in intron 8 of the sterol
RT   regulatory element-binding protein cleavage-activating protein gene
RT   allowing direct regulation by the androgen receptor.";
RL   J. Biol. Chem. 279:30880-30887(2004).
RN   [8]
RP   INTERACTION WITH INSIG2.
RX   PubMed=17428920; DOI=10.1073/pnas.0700899104;
RA   Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., Goldstein J.L.;
RT   "Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi:
RT   oxysterols block transport by binding to Insig.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:6511-6518(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-907, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   INTERACTION WITH INSIG2.
RX   PubMed=26160948; DOI=10.1126/science.aab1091;
RA   Ren R., Zhou X., He Y., Ke M., Wu J., Liu X., Yan C., Wu Y., Gong X.,
RA   Lei X., Yan S.F., Radhakrishnan A., Yan N.;
RT   "Crystal structure of a mycobacterial Insig homolog provides insight into
RT   how these sensors monitor sterol levels.";
RL   Science 349:187-191(2015).
RN   [11]
RP   INTERACTION WITH RNF139.
RX   PubMed=19706601; DOI=10.1074/jbc.m109.041376;
RA   Irisawa M., Inoue J., Ozawa N., Mori K., Sato R.;
RT   "The sterol-sensing endoplasmic reticulum (ER) membrane protein TRC8
RT   hampers ER to Golgi transport of sterol regulatory element-binding protein-
RT   2 (SREBP-2)/SREBP cleavage-activated protein and reduces SREBP-2
RT   cleavage.";
RL   J. Biol. Chem. 284:28995-29004(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-822; SER-838; SER-851 AND
RP   SER-907, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-822 AND SER-937, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   FUNCTION, INTERACTION WITH PAQR3, AND SUBCELLULAR LOCATION.
RX   PubMed=26311497; DOI=10.1038/ncomms9100;
RA   Xu D., Wang Z., Zhang Y., Jiang W., Pan Y., Song B.L., Chen Y.;
RT   "PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to
RT   the Golgi apparatus.";
RL   Nat. Commun. 6:8100-8100(2015).
RN   [16]
RP   REVIEW.
RX   PubMed=28849786; DOI=10.1038/nrendo.2017.91;
RA   Shimano H., Sato R.;
RT   "SREBP-regulated lipid metabolism: convergent physiology - divergent
RT   pathophysiology.";
RL   Nat. Rev. Endocrinol. 13:710-730(2017).
RN   [17]
RP   INTERACTION WITH SPRING1, AND SUBCELLULAR LOCATION.
RX   PubMed=32111832; DOI=10.1038/s41467-020-14811-1;
RA   Loregger A., Raaben M., Nieuwenhuis J., Tan J.M.E., Jae L.T.,
RA   van den Hengel L.G., Hendrix S., van den Berg M., Scheij S., Song J.Y.,
RA   Huijbers I.J., Kroese L.J., Ottenhoff R., van Weeghel M., van de Sluis B.,
RA   Brummelkamp T., Zelcer N.;
RT   "Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP
RT   signaling and cholesterol metabolism.";
RL   Nat. Commun. 11:1128-1128(2020).
RN   [18]
RP   VARIANT ILE-798.
RX   PubMed=10570919; DOI=10.1007/s100380050193;
RA   Iwaki K., Nakajima T., Ota N., Emi M.;
RT   "A common Ile796Val polymorphism of the human SREBP cleavage-activating
RT   protein (SCAP) gene.";
RL   J. Hum. Genet. 44:421-422(1999).
CC   -!- FUNCTION: Escort protein required for cholesterol as well as lipid
CC       homeostasis (By similarity). Regulates export of the SCAP-SREBP complex
CC       from the endoplasmic reticulum to the Golgi upon low cholesterol,
CC       thereby regulating the processing of sterol regulatory element-binding
CC       proteins (SREBPs) SREBF1/SREBP1 and SREBF2/SREBP2 (PubMed:26311497). At
CC       high sterol concentrations, formation of a ternary complex with INSIG
CC       (INSIG1 or INSIG2) leads to mask the ER export signal in SCAP,
CC       promoting retention of the complex in the endoplasmic reticulum (By
CC       similarity). Low sterol concentrations trigger release of INSIG, a
CC       conformational change in the SSD domain of SCAP, unmasking of the ER
CC       export signal, promoting recruitment into COPII-coated vesicles and
CC       transport of the SCAP-SREBP to the Golgi: in the Golgi, SREBPs are then
CC       processed, releasing the transcription factor fragment of SREBPs from
CC       the membrane, its import into the nucleus and up-regulation of LDLR,
CC       INSIG1 and the mevalonate pathway (PubMed:26311497). Binds cholesterol
CC       via its SSD domain (By similarity). {ECO:0000250|UniProtKB:P97260,
CC       ECO:0000269|PubMed:26311497}.
CC   -!- SUBUNIT: Membrane region forms a homotetramer (By similarity).
CC       Component of the SCAP-SREBP complex (composed of SCAP and SREBF1/SREBP1
CC       or SREBF2/SREBP2); interacts with SREBF1/SREBP1 or SREBF2/SREBP2
CC       through its C-terminal cytoplasmic domain (PubMed:26311497). Forms a
CC       ternary complex with INSIG1 or INSIG2 through its transmembrane domains
CC       at high sterol concentrations (PubMed:17428920, PubMed:26160948).
CC       Interacts with PAQR3; the interaction anchors the SCAP-SREBP complex to
CC       the Golgi apparatus in low cholesterol conditions (PubMed:26311497).
CC       Interacts with the SEC23-SEC24 complex in a SAR1-GTP-dependent manner
CC       through an ER export signal in its third cytoplasmic loop (By
CC       similarity). Interacts with RNF139; the interaction inhibits the
CC       interaction of SCAP with SEC24B and hampering the ER to Golgi transport
CC       of the SCAP-SREBP complex (PubMed:19706601). Interacts with SPRING1
CC       (PubMed:32111832). {ECO:0000250|UniProtKB:P97260,
CC       ECO:0000269|PubMed:17428920, ECO:0000269|PubMed:19706601,
CC       ECO:0000269|PubMed:26160948, ECO:0000269|PubMed:26311497,
CC       ECO:0000269|PubMed:32111832}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:32111832}; Multi-pass membrane protein
CC       {ECO:0000255}. Golgi apparatus membrane {ECO:0000269|PubMed:26311497,
CC       ECO:0000269|PubMed:32111832}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, COPII-coated vesicle membrane
CC       {ECO:0000250|UniProtKB:P97260}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Moves from the endoplasmic reticulum to the Golgi
CC       in the absence of sterols (PubMed:26311497). Requires the presence of
CC       SPRING1 for proper localization to endoplasmic reticulum
CC       (PubMed:32111832). {ECO:0000250|UniProtKB:P97260,
CC       ECO:0000269|PubMed:26311497, ECO:0000269|PubMed:32111832}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q12770-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12770-2; Sequence=VSP_007451, VSP_021106;
CC       Name=3;
CC         IsoId=Q12770-3; Sequence=VSP_007452;
CC       Name=4;
CC         IsoId=Q12770-4; Sequence=VSP_021105, VSP_021106;
CC   -!- INDUCTION: By androgen-bound AR and glucocorticoid-bound NR3C1 in a
CC       prostate cancer cell line (LNCaP). {ECO:0000269|PubMed:15133039}.
CC   -!- DOMAIN: Loop-1 binds to loop-7, enabling interaction with COPII-coated
CC       vesicles. When levels of cholesterol in the endoplasmic reticulum
CC       increase, Loop-1 binds to cholesterol instead, thereby disrupting
CC       direct binding between the two loops and preventing the SCAP-SREBP
CC       complex from exiting the endoplasmic reticulum.
CC       {ECO:0000250|UniProtKB:P97260}.
CC   -!- DOMAIN: Cholesterol bound to SSD domain of SCAP or oxysterol bound to
CC       INSIG (INSIG1 or INSIG2) leads to masking of an ER export signal (also
CC       named MELADL motif) on SCAP possibly by moving the signal further away
CC       from the ER membrane. {ECO:0000250|UniProtKB:P97260}.
CC   -!- PTM: Ubiquitinated at Lys-454 and Lys-466. RNF145 triggers
CC       ubiquitination of SCAP, likely inhibiting SCAP-SREBP complex transport
CC       to the Golgi apparatus and the subsequent processing/maturation of
CC       SREBF2/SREBP2. {ECO:0000250|UniProtKB:Q6GQT6}.
CC   -!- SIMILARITY: Belongs to the WD repeat SCAP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA12111.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC11673.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D83782; BAA12111.2; ALT_INIT; mRNA.
DR   EMBL; AK027402; BAB55088.1; -; mRNA.
DR   EMBL; BC020987; AAH20987.1; -; mRNA.
DR   EMBL; AK075528; BAC11673.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2755.2; -. [Q12770-1]
DR   RefSeq; NP_036367.2; NM_012235.4. [Q12770-1]
DR   RefSeq; XP_011531803.1; XM_011533501.2. [Q12770-1]
DR   RefSeq; XP_016861407.1; XM_017005918.2. [Q12770-1]
DR   RefSeq; XP_047303688.1; XM_047447732.1. [Q12770-1]
DR   RefSeq; XP_047303689.1; XM_047447733.1. [Q12770-1]
DR   RefSeq; XP_047303690.1; XM_047447734.1. [Q12770-1]
DR   RefSeq; XP_047303691.1; XM_047447735.1. [Q12770-1]
DR   RefSeq; XP_047303692.1; XM_047447736.1. [Q12770-1]
DR   PDB; 6M49; EM; 3.70 A; B=1-735.
DR   PDB; 7ETW; EM; 4.10 A; B=1-735.
DR   PDBsum; 6M49; -.
DR   PDBsum; 7ETW; -.
DR   AlphaFoldDB; Q12770; -.
DR   EMDB; EMD-30074; -.
DR   EMDB; EMD-31303; -.
DR   SMR; Q12770; -.
DR   BioGRID; 116596; 144.
DR   ComplexPortal; CPX-25721; SREBP-SCAP transcription regulator complex, SREBF2 variant.
DR   ComplexPortal; CPX-25745; SREBP-SCAP transcription regulator complex, SREBF1 variant.
DR   CORUM; Q12770; -.
DR   FunCoup; Q12770; 1476.
DR   IntAct; Q12770; 118.
DR   MINT; Q12770; -.
DR   STRING; 9606.ENSP00000265565; -.
DR   ChEMBL; CHEMBL4879458; -.
DR   GlyCosmos; Q12770; 3 sites, No reported glycans.
DR   GlyGen; Q12770; 5 sites, 5 N-linked glycans (3 sites), 2 O-linked glycans (2 sites).
DR   iPTMnet; Q12770; -.
DR   PhosphoSitePlus; Q12770; -.
DR   SwissPalm; Q12770; -.
DR   BioMuta; SCAP; -.
DR   DMDM; 116242783; -.
DR   jPOST; Q12770; -.
DR   MassIVE; Q12770; -.
DR   PaxDb; 9606-ENSP00000265565; -.
DR   PeptideAtlas; Q12770; -.
DR   ProteomicsDB; 58915; -. [Q12770-1]
DR   ProteomicsDB; 58916; -. [Q12770-2]
DR   ProteomicsDB; 58917; -. [Q12770-3]
DR   ProteomicsDB; 58918; -. [Q12770-4]
DR   Pumba; Q12770; -.
DR   TopDownProteomics; Q12770-2; -. [Q12770-2]
DR   Antibodypedia; 1330; 233 antibodies from 27 providers.
DR   DNASU; 22937; -.
DR   Ensembl; ENST00000265565.10; ENSP00000265565.5; ENSG00000114650.22. [Q12770-1]
DR   Ensembl; ENST00000648151.1; ENSP00000497087.1; ENSG00000114650.22. [Q12770-1]
DR   GeneID; 22937; -.
DR   KEGG; hsa:22937; -.
DR   MANE-Select; ENST00000265565.10; ENSP00000265565.5; NM_012235.4; NP_036367.2.
DR   UCSC; uc003crh.2; human. [Q12770-1]
DR   AGR; HGNC:30634; -.
DR   ClinPGx; PA162402461; -.
DR   CTD; 22937; -.
DR   DisGeNET; 22937; -.
DR   GeneCards; SCAP; -.
DR   HGNC; HGNC:30634; SCAP.
DR   HPA; ENSG00000114650; Low tissue specificity.
DR   MIM; 601510; gene.
DR   OpenTargets; ENSG00000114650; -.
DR   VEuPathDB; HostDB:ENSG00000114650; -.
DR   eggNOG; KOG1933; Eukaryota.
DR   GeneTree; ENSGT00940000158130; -.
DR   HOGENOM; CLU_006510_0_0_1; -.
DR   InParanoid; Q12770; -.
DR   OMA; IMKQYNV; -.
DR   OrthoDB; 361494at2759; -.
DR   PAN-GO; Q12770; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q12770; -.
DR   PathwayCommons; Q12770; -.
DR   Reactome; R-HSA-1655829; Regulation of cholesterol biosynthesis by SREBP (SREBF).
DR   SignaLink; Q12770; -.
DR   SIGNOR; Q12770; -.
DR   Agora; ENSG00000114650; -.
DR   BioGRID-ORCS; 22937; 587 hits in 1197 CRISPR screens.
DR   ChiTaRS; SCAP; human.
DR   GeneWiki; SREBP_cleavage_activating_protein; -.
DR   GenomeRNAi; 22937; -.
DR   Pharos; Q12770; Tbio.
DR   PRO; PR:Q12770; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q12770; protein.
DR   Bgee; ENSG00000114650; Expressed in adrenal tissue and 205 other cell types or tissues.
DR   ExpressionAtlas; Q12770; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; NAS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; NAS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0032936; C:SREBP-SCAP complex; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0032934; F:sterol binding; ISS:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; NAS:UniProtKB.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISS:UniProtKB.
DR   GO; GO:0090110; P:COPII-coated vesicle cargo loading; ISS:UniProtKB.
DR   GO; GO:0006955; P:immune response; IEA:Ensembl.
DR   GO; GO:0045541; P:negative regulation of cholesterol biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0045542; P:positive regulation of cholesterol biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045540; P:regulation of cholesterol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0042304; P:regulation of fatty acid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0033552; P:response to vitamin B3; IEA:Ensembl.
DR   GO; GO:0032933; P:SREBP signaling pathway; IDA:UniProtKB.
DR   FunFam; 2.130.10.10:FF:000209; sterol regulatory element-binding protein cleavage-activating protein-like; 1.
DR   FunFam; 2.130.10.10:FF:000391; sterol regulatory element-binding protein cleavage-activating protein-like; 1.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 2.
DR   InterPro; IPR057042; Beta-prop_SCAP.
DR   InterPro; IPR053958; HMGCR/SNAP/NPC1-like_SSD.
DR   InterPro; IPR030225; SCAP.
DR   InterPro; IPR057041; SCAP_N.
DR   InterPro; IPR000731; SSD.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   InterPro; IPR001680; WD40_rpt.
DR   PANTHER; PTHR46378; STEROL REGULATORY ELEMENT-BINDING PROTEIN CLEAVAGE-ACTIVATING PROTEIN; 1.
DR   PANTHER; PTHR46378:SF1; STEROL REGULATORY ELEMENT-BINDING PROTEIN CLEAVAGE-ACTIVATING PROTEIN; 1.
DR   Pfam; PF24017; Beta-prop_SCAP; 1.
DR   Pfam; PF24006; SCAP_N; 1.
DR   Pfam; PF12349; Sterol-sensing; 1.
DR   SMART; SM00320; WD40; 6.
DR   SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 1.
DR   SUPFAM; SSF50978; WD40 repeat-like; 1.
DR   PROSITE; PS50156; SSD; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol metabolism;
KW   Cytoplasmic vesicle; Endoplasmic reticulum; Glycoprotein; Golgi apparatus;
KW   Isopeptide bond; Lipid metabolism; Lipid-binding; Membrane; Methylation;
KW   Phosphoprotein; Proteomics identification; Reference proteome; Repeat;
KW   Steroid metabolism; Sterol metabolism; Transmembrane; Transmembrane helix;
KW   Ubl conjugation; WD repeat.
FT   CHAIN           1..1279
FT                   /note="Sterol regulatory element-binding protein cleavage-
FT                   activating protein"
FT                   /id="PRO_0000051208"
FT   TOPO_DOM        1..18
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        19..39
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        40..279
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        280..300
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        301..312
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        313..333
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        334..344
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        345..365
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        366..401
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        402..422
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        423
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        424..444
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        445..518
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        519..539
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        540..709
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   TRANSMEM        710..730
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        731..1279
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   DOMAIN          284..442
FT                   /note="SSD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00199"
FT   REPEAT          771..811
FT                   /note="WD 1"
FT   REPEAT          952..1002
FT                   /note="WD 2"
FT   REPEAT          1005..1042
FT                   /note="WD 3"
FT   REPEAT          1077..1114
FT                   /note="WD 4"
FT   REPEAT          1117..1155
FT                   /note="WD 5"
FT   REPEAT          1158..1195
FT                   /note="WD 6"
FT   REPEAT          1197..1235
FT                   /note="WD 7"
FT   REGION          46..284
FT                   /note="Loop-1"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   REGION          60..80
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          535..710
FT                   /note="Loop-7"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   REGION          579..615
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          668..696
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          731..1279
FT                   /note="Interaction with SREBF2"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   REGION          811..904
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          931..962
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           447..452
FT                   /note="ER export signal"
FT                   /evidence="ECO:0000250|UniProtKB:P97260"
FT   COMPBIAS        877..891
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         822
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         838
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         851
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         907
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         937
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1051
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GQT6"
FT   CARBOHYD        263
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        590
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        641
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        454
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GQT6"
FT   CROSSLNK        466
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q6GQT6"
FT   VAR_SEQ         1..392
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021105"
FT   VAR_SEQ         29..401
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007451"
FT   VAR_SEQ         476..983
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16303743"
FT                   /id="VSP_007452"
FT   VAR_SEQ         817
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021106"
FT   VARIANT         798
FT                   /note="V -> I (in dbSNP:rs12487736)"
FT                   /evidence="ECO:0000269|PubMed:10570919"
FT                   /id="VAR_012203"
FT   CONFLICT        350
FT                   /note="P -> G (in Ref. 6; BAC11673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        427
FT                   /note="S -> T (in Ref. 6; BAC11673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        617
FT                   /note="W -> R (in Ref. 4; BAB55088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        753
FT                   /note="L -> Q (in Ref. 4; BAB55088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        941
FT                   /note="V -> A (in Ref. 4; BAB55088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        994
FT                   /note="A -> S (in Ref. 6; BAC11673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1019
FT                   /note="R -> G (in Ref. 6; BAC11673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1035
FT                   /note="E -> G (in Ref. 4; BAB55088)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1080
FT                   /note="K -> E (in Ref. 4; BAB55088)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1279 AA;  139729 MW;  4CD73543B7D2ACB4 CRC64;
     MTLTERLREK ISRAFYNHGL LCASYPIPII LFTGFCILAC CYPLLKLPLP GTGPVEFTTP
     VKDYSPPPVD SDRKQGEPTE QPEWYVGAPV AYVQQIFVKS SVFPWHKNLL AVDVFRSPLS
     RAFQLVEEIR NHVLRDSSGI RSLEELCLQV TDLLPGLRKL RNLLPEHGCL LLSPGNFWQN
     DWERFHADPD IIGTIHQHEP KTLQTSATLK DLLFGVPGKY SGVSLYTRKR MVSYTITLVF
     QHYHAKFLGS LRARLMLLHP SPNCSLRAES LVHVHFKEEI GVAELIPLVT TYIILFAYIY
     FSTRKIDMVK SKWGLALAAV VTVLSSLLMS VGLCTLFGLT PTLNGGEIFP YLVVVIGLEN
     VLVLTKSVVS TPVDLEVKLR IAQGLSSESW SIMKNMATEL GIILIGYFTL VPAIQEFCLF
     AVVGLVSDFF LQMLFFTTVL SIDIRRMELA DLNKRLPPEA CLPSAKPVGQ PTRYERQLAV
     RPSTPHTITL QPSSFRNLRL PKRLRVVYFL ARTRLAQRLI MAGTVVWIGI LVYTDPAGLR
     NYLAAQVTEQ SPLGEGALAP MPVPSGMLPP SHPDPAFSIF PPDAPKLPEN QTSPGESPER
     GGPAEVVHDS PVPEVTWGPE DEELWRKLSF RHWPTLFSYY NITLAKRYIS LLPVIPVTLR
     LNPREALEGR HPQDGRSAWP PPGPIPAGHW EAGPKGPGGV QAHGDVTLYK VAALGLATGI
     VLVLLLLCLY RVLCPRNYGQ LGGGPGRRRR GELPCDDYGY APPETEIVPL VLRGHLMDIE
     CLASDGMLLV SCCLAGHVCV WDAQTGDCLT RIPRPGRQRR DSGVGSGLEA QESWERLSDG
     GKAGPEEPGD SPPLRHRPRG PPPPSLFGDQ PDLTCLIDTN FSAQPRSSQP TQPEPRHRAV
     CGRSRDSPGY DFSCLVQRVY QEEGLAAVCT PALRPPSPGP VLSQAPEDEG GSPEKGSPSL
     AWAPSAEGSI WSLELQGNLI VVGRSSGRLE VWDAIEGVLC CSSEEVSSGI TALVFLDKRI
     VAARLNGSLD FFSLETHTAL SPLQFRGTPG RGSSPASPVY SSSDTVACHL THTVPCAHQK
     PITALKAAAG RLVTGSQDHT LRVFRLEDSC CLFTLQGHSG AITTVYIDQT MVLASGGQDG
     AICLWDVLTG SRVSHVFAHR GDVTSLTCTT SCVISSGLDD LISIWDRSTG IKFYSIQQDL
     GCGASLGVIS DNLLVTGGQG CVSFWDLNYG DLLQTVYLGK NSEAQPARQI LVLDNAAIVC
     NFGSELSLVY VPSVLEKLD
//
